{"id":19268,"date":"2025-09-25T04:17:48","date_gmt":"2025-09-24T12:17:48","guid":{"rendered":"https:\/\/www.hjtdsm.cn\/stem-cells\/nsc\/19268.html"},"modified":"2025-10-13T14:52:34","modified_gmt":"2025-10-13T06:52:34","slug":"%e7%a5%9e%e7%bb%8f%e5%b9%b2%e7%bb%86%e8%83%9e%e7%a7%bb%e6%a4%8d%e8%b4%b9%e7%94%a8%e4%b8%8e%e5%8c%bb%e4%bf%9d%e6%8a%a5%e9%94%80%e5%ae%8c%e5%85%a8%e6%8c%87%e5%8d%97%ef%bc%882025%e6%9c%80%e6%96%b0","status":"publish","type":"post","link":"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html","title":{"rendered":"Complete Guide to Neural Stem Cell Transplant Costs and Medicare Reimbursement (2025 Update)"},"content":{"rendered":"<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>As of June 2025<strong><span class=\"xintheme_tag_link\">neural stem cell transplantation<\/span>The cost of a single treatment is between 70,000 and 120,000 RMB.<\/strong>If multiple treatments are required over a long period of time (e.g., Parkinson's disease, spinal cord injuries, etc.), the total cost may be up to<strong>$280,000 to $480,000<\/strong>. Costs primarily cover cell preparation (accounting for 50%-60%), surgical implantation, postoperative monitoring, and long-term medication management.<\/p><\/blockquote>\n<p><strong>Currently, neural stem cell transplantation is not covered by the national basic health insurance routine reimbursement coverage<\/strong>. According to the Beijing Municipal Health Insurance Bureau's 2024 release, \"Beijing Health Insurance Issuance [2024] No. 16,\" only the<strong>Hematopoietic stem cell transplantation for 12 types of hematologic diseases and some genetic diseases<\/strong>Surgical and hospitalization costs (at a rate of 50%-70%) are reimbursed, but donor-related costs (e.g., matching, transportation) remain out-of-pocket.<\/p>\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone\" src=\"https:\/\/www.hjtdsm.cn\/wp-content\/uploads\/2025\/09\/20250924201747-68d3e16b673c0.jpg\" alt=\"\u795e\u7ecf\u5e72\u7ec6\u80de\u79fb\u690d\u8d39\u7528\u4e0e\u533b\u4fdd\u62a5\u9500\u5b8c\u5168\u6307\u5357\uff082025\u6700\u65b0\u7248\uff09\" width=\"612\" height=\"428\" title=\"\"><\/figure>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_79_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#%E4%B8%80%E3%80%81%E7%A5%9E%E7%BB%8F%E5%B9%B2%E7%BB%86%E8%83%9E%E7%A7%BB%E6%A4%8D%E8%B4%B9%E7%94%A8%E5%85%A8%E6%99%AF%EF%BC%9A%E5%8D%95%E6%AC%A1%E6%B2%BB%E7%96%97%E5%88%B0%E9%95%BF%E6%9C%9F%E7%96%97%E7%A8%8B%E7%9A%84%E6%B7%B1%E5%BA%A6%E8%A7%A3%E6%9E%90\" >A panorama of neural stem cell transplantation costs: an in-depth analysis of single treatments to long-term regimens<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#11_%E6%A0%B8%E5%BF%83%E8%B4%B9%E7%94%A8%E6%9E%84%E6%88%90%E8%A7%A3%E6%9E%90\" >1.1 Analysis of core cost components<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#12_%E5%9B%BD%E5%86%85%E5%A4%96%E8%B4%B9%E7%94%A8%E5%B7%AE%E5%BC%82%E5%88%86%E6%9E%90\" >1.2 Analysis of domestic and external cost differentials<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#%E4%BA%8C%E3%80%81%E5%8C%BB%E4%BF%9D%E6%8A%A5%E9%94%80%E7%8E%B0%E7%8A%B6%E4%B8%8E%E7%AA%81%E7%A0%B4%EF%BC%9A%E6%94%BF%E7%AD%96%E7%BA%A2%E5%88%A9%E4%B8%8E%E5%95%86%E4%B8%9A%E4%BF%9D%E9%99%A9%E7%9A%84%E5%8D%8F%E5%90%8C%E4%BD%9C%E7%94%A8\" >II. Status quo and breakthroughs in health insurance reimbursement: synergies between policy dividends and commercial insurance<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#21_%E5%9B%BD%E5%AE%B6%E5%9F%BA%E6%9C%AC%E5%8C%BB%E4%BF%9D%E7%9A%84%E8%A6%86%E7%9B%96%E5%B1%80%E9%99%90\" >2.1 Limitations of coverage under the National Basic Health Insurance (NBHI)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#22_%E5%9C%B0%E6%96%B9%E6%94%BF%E7%AD%96%E6%80%A7%E7%AA%81%E7%A0%B4%E4%B8%8E%E5%95%86%E4%B8%9A%E4%BF%9D%E9%99%A9%E8%A1%A5%E5%85%85\" >2.2 Local policy breakthroughs and commercial insurance supplements<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#23_%E8%B4%B9%E7%94%A8%E5%87%8F%E5%85%8D%E7%9A%84%E7%89%B9%E4%BE%8B%E5%9C%BA%E6%99%AF\" >2.3 Special case scenarios for fee waivers<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#%E4%B8%89%E3%80%81%E9%99%8D%E4%BD%8E%E6%B2%BB%E7%96%97%E6%88%90%E6%9C%AC%E7%9A%84%E4%BA%94%E5%A4%A7%E5%AE%9E%E7%94%A8%E6%96%B9%E6%B3%95\" >III. Five practical ways to reduce treatment costs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#31_%E9%98%B6%E6%A2%AF%E5%BC%8F%E6%B2%BB%E7%96%97%E7%AD%96%E7%95%A5%EF%BC%9A%E4%BB%8E%E5%9F%BA%E7%A1%80%E5%88%B0%E5%BC%BA%E5%8C%96\" >3.1 Laddered treatment strategies: from basic to intensive<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#32_%E7%B2%BE%E5%87%86%E5%AF%B9%E6%8E%A5%E5%85%8D%E8%B4%B9%E5%8C%BB%E7%96%97%E8%B5%84%E6%BA%90\" >3.2 Accurate matching of free medical resources<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#33_%E5%96%84%E7%94%A8%E6%94%BF%E7%AD%96%E5%B7%A5%E5%85%B7%E8%B7%A8%E7%9C%81%E6%8A%A5%E9%94%80\" >3.3 Optimizing the use of policy tools for inter-provincial reimbursement<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#%E5%9B%9B%E3%80%81%E6%9C%AA%E6%9D%A5%E8%B6%8B%E5%8A%BF%E4%B8%8E%E6%82%A3%E8%80%85%E8%A1%8C%E5%8A%A8%E6%8C%87%E5%8D%97\" >IV. Future trends and guidelines for patient action<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#41_%E6%94%BF%E7%AD%96%E4%B8%8E%E6%8A%80%E6%9C%AF%E9%A9%B1%E5%8A%A8%E7%9A%84%E9%99%8D%E4%BB%B7%E8%B6%8B%E5%8A%BF\" >4.1 Policy- and technology-driven price reduction trends<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.hjtdsm.cn\/en\/stem-cells\/nsc\/19268.html\/#%E7%BB%93%E8%AF%AD%EF%BC%9A%E7%90%86%E6%80%A7%E5%BA%94%E5%AF%B9%E8%B4%B9%E7%94%A8%E6%8C%91%E6%88%98%EF%BC%8C%E6%8A%8A%E6%8F%A1%E6%94%BF%E7%AD%96%E8%BD%AC%E5%9E%8B%E6%9C%BA%E9%81%87\" >Conclusion: Rationalizing the Cost Challenge and Seizing the Opportunity for Policy Transformation<\/a><\/li><\/ul><\/nav><\/div>\n<h2 id=\"h-\u4e00-\u795e\u7ecf\u5e72\u7ec6\u80de\u79fb\u690d\u8d39\u7528\u5168\u666f-\u5355\u6b21\u6cbb\u7597\u5230\u957f\u671f\u7597\u7a0b\u7684\u6df1\u5ea6\u89e3\u6790\"><span class=\"ez-toc-section\" id=\"%E4%B8%80%E3%80%81%E7%A5%9E%E7%BB%8F%E5%B9%B2%E7%BB%86%E8%83%9E%E7%A7%BB%E6%A4%8D%E8%B4%B9%E7%94%A8%E5%85%A8%E6%99%AF%EF%BC%9A%E5%8D%95%E6%AC%A1%E6%B2%BB%E7%96%97%E5%88%B0%E9%95%BF%E6%9C%9F%E7%96%97%E7%A8%8B%E7%9A%84%E6%B7%B1%E5%BA%A6%E8%A7%A3%E6%9E%90\"><\/span>A panorama of neural stem cell transplantation costs: an in-depth analysis of single treatments to long-term regimens<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neural stem cell transplantation, a cutting-edge treatment for neurodegenerative diseases and injuries, has a complex cost structure and is influenced by multiple factors. According to the latest clinical data from the 2025<strong>Cost of a single neural stem cell transplant<\/strong>between $60,000 and $100,000, and for chronic diseases such as Parkinson's disease and spinal cord injuries<strong>Long-term comprehensive treatment<\/strong>(Usually 3-5 transplants are required.) The cost can be as high as $200,000 to $500,000 dollars. Such high costs pose a huge financial challenge to most ordinary families.<\/p>\n<h3 id=\"h-1-1-\u6838\u5fc3\u8d39\u7528\u6784\u6210\u89e3\u6790\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"11_%E6%A0%B8%E5%BF%83%E8%B4%B9%E7%94%A8%E6%9E%84%E6%88%90%E8%A7%A3%E6%9E%90\"><\/span>1.1 Analysis of core cost components<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The total cost of neural stem cell transplantation is made up of the following key components:<\/p>\n<p><strong>Cell Preparation and QC Costs (of total costs 50%-60%)<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>Cell collection: Stem cells are obtained from autologous bone marrow or adipose tissue at a cost of about $20,000-$50,000; allogeneic sources are subject to an additional matching fee ($5,000\/trial) and donor reimbursement.<\/li>\n<li>Laboratory expansion and culture: GMP standard laboratory is used for neural stem cell directed differentiation, which takes 4-6 weeks and costs 100,000-200,000 RMB.<\/li>\n<li>Cell quality control assays: including<strong>sterility testing<\/strong>(Bacteria\/Fungi\/Mycoplasma),<strong>Cell Activity Assay<\/strong>(&gt;90% is qualified),<strong>phenotyping<\/strong>(CD markers) and<strong>Genomic Stability Validation<\/strong>, costing about $20,000-$50,000 dollars.<\/li>\n<\/ul>\n<p><strong>Medical Operations and Hospitalization Costs (of total costs 25%-35%)<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>Surgical implantation: stereotactic intracerebral injection or localized spinal cord injection, surgical fee 5,000 RMB;<\/li>\n<li>Postoperative monitoring: Includes 24-hour neurological monitoring and complication management at an average daily cost of $500-$2,000 and usually requires 7-14 days of hospitalization.<\/li>\n<li>Intraoperative image navigation: Intraoperative MRI or CT guidance for precise localization adds $10,000-30,000 to the cost;<\/li>\n<\/ul>\n<p><strong>Complementary Therapies and Long-Term Management (15%-25% of total costs)<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>Immunosuppressants: tacrolimus and other drugs are needed after allogeneic transplantation; imported drugs are about $16,000\/month, and domestically produced drugs can reduce the cost of 40%;<\/li>\n<li>Rehabilitation therapy: Neurological function training, physiotherapy, etc., 0.5-10,000 yuan per month;<\/li>\n<li>Follow-up monitoring: Periodic PET-CT or functional MRI, $0.5 - $10,000 per visit;<\/li>\n<\/ul>\n<p><em>Table : Cost Comparison of Neural Stem Cell Transplantation for Different Neurological Disorders (2025 Data)<\/em><\/p>\n<figure class=\"wp-block-table is-style-stripes\">\n<table class=\"has-fixed-layout\">\n<thead>\n<tr>\n<th><strong>indications<\/strong><\/th>\n<th><strong>treatment plan<\/strong><\/th>\n<th><strong>Single cost range<\/strong><\/th>\n<th><strong>Recommended Treatment<\/strong><\/th>\n<th><strong>Total cost estimate<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>spinal cord injury<\/strong><\/td>\n<td>Local injection of lesions + intravenous infusion<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">$70,000-$100,000<\/span><\/span><\/td>\n<td>2-3 times<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">210,000-300,000 dollars<\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td><strong>Parkinson's disease<\/strong><\/td>\n<td>Targeted implantation in the substantia nigra region of the brain<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">80,000-110,000 dollars<\/span><\/span><\/td>\n<td>1-2 (additional)<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">$160,000-$220,000<\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td><strong>(medicine) sequelae of stroke<\/strong><\/td>\n<td>Intravenous infusions predominate<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">$70,000-$100,000<\/span><\/span><\/td>\n<td>3-4 times<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">210,000-400,000 dollars<\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td><strong>senile dementia<\/strong><\/td>\n<td>Multi-point injection in Haima district<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">$70,000-$100,000<\/span><\/span><\/td>\n<td>Single + periodic reinforcement<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">$280,000-$500,000<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table><figcaption class=\"wp-element-caption\"><em><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Table : Cost Comparison of Neural Stem Cell Transplantation for Different Neurological Disorders (2025 Data)<\/span><\/span><\/em><\/figcaption><\/figure>\n<h3 id=\"h-1-2-\u56fd\u5185\u5916\u8d39\u7528\u5dee\u5f02\u5206\u6790\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12_%E5%9B%BD%E5%86%85%E5%A4%96%E8%B4%B9%E7%94%A8%E5%B7%AE%E5%BC%82%E5%88%86%E6%9E%90\"><\/span>1.2 Analysis of domestic and external cost differentials<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Choosing overseas treatment needs to be weighed carefully against value for money. Data shows that the Mayo Clinic in the United States charges as much as $10,000 for a neural stem cell transplant.<strong>500,000-2 million dollars<\/strong>\/ time, the cost of the National Center for Research on Sengoku Medicine in Japan is approximately<strong>$300,000-$800,000<\/strong>, while organizations such as Bangkok Hospital in Thailand are known for<strong>$200,000 - $400,000<\/strong>prices to attract international patients.9 Notably, the<strong>Domestic high-end medical institutions<\/strong>(e.g., neurosurgery departments of Beijing Tiantan Hospital and Shanghai Huashan Hospital) are close to the international level, and the cost is controlled at<strong>$250,000-$500,000<\/strong>and<strong>No need to bear the cost of traveling for cross-border medical treatment<\/strong>The<\/p>\n<h2 id=\"h-\u4e8c-\u533b\u4fdd\u62a5\u9500\u73b0\u72b6\u4e0e\u7a81\u7834-\u653f\u7b56\u7ea2\u5229\u4e0e\u5546\u4e1a\u4fdd\u9669\u7684\u534f\u540c\u4f5c\u7528\"><span class=\"ez-toc-section\" id=\"%E4%BA%8C%E3%80%81%E5%8C%BB%E4%BF%9D%E6%8A%A5%E9%94%80%E7%8E%B0%E7%8A%B6%E4%B8%8E%E7%AA%81%E7%A0%B4%EF%BC%9A%E6%94%BF%E7%AD%96%E7%BA%A2%E5%88%A9%E4%B8%8E%E5%95%86%E4%B8%9A%E4%BF%9D%E9%99%A9%E7%9A%84%E5%8D%8F%E5%90%8C%E4%BD%9C%E7%94%A8\"><\/span>II. Status quo and breakthroughs in health insurance reimbursement: synergies between policy dividends and commercial insurance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 id=\"h-2-1-\u56fd\u5bb6\u57fa\u672c\u533b\u4fdd\u7684\u8986\u76d6\u5c40\u9650\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"21_%E5%9B%BD%E5%AE%B6%E5%9F%BA%E6%9C%AC%E5%8C%BB%E4%BF%9D%E7%9A%84%E8%A6%86%E7%9B%96%E5%B1%80%E9%99%90\"><\/span>2.1 Limitations of coverage under the National Basic Health Insurance (NBHI)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As of June 2025, the National Health Insurance Catalog for neural stem cell transplants is still<strong>Full coverage not achieved<\/strong>. Existing policies are largely skewed in favor of<strong>Hematopoietic Stem Cell Transplantation for Blood Disorders<\/strong>, such as the Beijing Municipal Health Insurance Bureau's November 2024 release of Beijing Health Insurance Fa [2024] No. 16, which explicitly includes hematopoietic stem cell transplants for leukemia, lymphoma, and other 12 types of hematologic disorders in the reimbursement scope, but the<strong>Neural stem cells not included in payment<\/strong>The<\/p>\n<p>However, positive signals are emerging from the policy. Through the \"Boaikang\" universal commercial insurance, Guangdong Province has provided a number of benefits for<strong>Patients with nerve damage from rare diseases<\/strong>of outpatient drug costs provide reimbursement of up to 601 TP3T. These pilot programs offer the possibility of future inclusion of neural stem cell therapy in Medicare.<\/p>\n<h3 id=\"h-2-2-\u5730\u65b9\u653f\u7b56\u6027\u7a81\u7834\u4e0e\u5546\u4e1a\u4fdd\u9669\u8865\u5145\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"22_%E5%9C%B0%E6%96%B9%E6%94%BF%E7%AD%96%E6%80%A7%E7%AA%81%E7%A0%B4%E4%B8%8E%E5%95%86%E4%B8%9A%E4%BF%9D%E9%99%A9%E8%A1%A5%E5%85%85\"><\/span>2.2 Local policy breakthroughs and commercial insurance supplements<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In some areas, the burden on patients has been reduced through a multi-level medical insurance system:<\/p>\n<p><strong>Local supplementary medical insurance<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>Beijing: Hematopoietic stem cell transplant patients treated in designated hospitals can be reimbursed for 50%-70% surgical hospitalization fees (no annual cap), but the<strong>cell harvesting fee<\/strong>,<strong>culture expansion fee<\/strong>Still fully self-paid.<\/li>\n<li>Zhongshan \"Boaikang\": patients with rare diseases (e.g. spinal muscular atrophy) using specific drugs (e.g. sodium nosinosonate) on an outpatient basis can be reimbursed for the out-of-pocket portion of more than 10,000 RMB after reimbursement by the basic medical insurance for 60%, with an annual limit of 200,000 RMB.<\/li>\n<\/ul>\n<p><strong>Specialized medical assistance<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>Chinese Red Cross Foundation: Nerve injury patients can apply for up to 200,000 RMB \"Angel Relief Fund\", need to provide proof of low income and treatment plan in a tertiary hospital.<\/li>\n<li>Welfare Foundation for the Disabled: Spinal cord injury patients with disability certificates can receive subsidies of $30,000-80,000 for rehabilitation treatment<\/li>\n<\/ul>\n<figure class=\"wp-block-table is-style-stripes\">\n<table class=\"has-fixed-layout\">\n<thead>\n<tr>\n<th><strong>Reimbursement channels<\/strong><\/th>\n<th><strong>Examples of covered items<\/strong><\/th>\n<th><strong>reimbursement rate<\/strong><\/th>\n<th><strong>minimum payment standard<\/strong><\/th>\n<th><strong>Requirements for application<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Basic medical insurance (Beijing)<\/strong><\/td>\n<td>Transplant surgery fees, hospitalization fees<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">50%-70%<\/span><\/span><\/td>\n<td>not have<\/td>\n<td>Limited to designated hospitals, blood diseases preferred<\/td>\n<\/tr>\n<tr>\n<td><strong>Universal Insurance (Boaikang)<\/strong><\/td>\n<td>Rare disease drugs, high value consumables<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">60%<\/span><\/span><\/td>\n<td>0.7 million - 1.7 million<\/td>\n<td>Participation in local health insurance<\/td>\n<\/tr>\n<tr>\n<td><strong>Charitable Medicine Giving Program<\/strong><\/td>\n<td>Immunosuppressants, neurotrophic drugs<\/td>\n<td>Free or 50%<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">not have<\/span><\/span><\/td>\n<td>Low income certificate + medical certificate<\/td>\n<\/tr>\n<tr>\n<td><strong>Clinical Research Program<\/strong><\/td>\n<td>Full course cell therapy fee<\/td>\n<td>full exemption<\/td>\n<td><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">not have<\/span><\/span><\/td>\n<td>Meets inclusion criteria<\/td>\n<\/tr>\n<\/tbody>\n<\/table><figcaption class=\"wp-element-caption\"><em>Table : Comparison of Reimbursement Pathways for Neural Stem Cell Therapy Costs (Applicable in 2025)<\/em><\/figcaption><\/figure>\n<h3 id=\"h-2-3-\u8d39\u7528\u51cf\u514d\u7684\u7279\u4f8b\u573a\u666f\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"23_%E8%B4%B9%E7%94%A8%E5%87%8F%E5%85%8D%E7%9A%84%E7%89%B9%E4%BE%8B%E5%9C%BA%E6%99%AF\"><\/span>2.3 Special case scenarios for fee waivers<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Two special cases may significantly reduce the patient's out-of-pocket percentage:<\/p>\n<p><strong>Clinical Trial Participation<\/strong>Phase I Clinical Study of Neural Stem Cells for Parkinson's Disease (NCT2025-0287) at Beijing Tiantan Hospital provides enrolled patients with<strong>Full free treatment<\/strong>The cost of cell preparation, surgery and follow-up is covered.<\/p>\n<p><strong>Critical Illness Insurance Benefits<\/strong>: Diagnosed in patients under 18 years of age<strong>medulloblastoma<\/strong>Zhongshan Boaikang offers 28 major diseases, including<strong>One-time fixed compensation of $20,000<\/strong>The<\/p>\n<h2 id=\"h-\u4e09-\u964d\u4f4e\u6cbb\u7597\u6210\u672c\u7684\u4e94\u5927\u5b9e\u6218\u8def\u5f84\"><span class=\"ez-toc-section\" id=\"%E4%B8%89%E3%80%81%E9%99%8D%E4%BD%8E%E6%B2%BB%E7%96%97%E6%88%90%E6%9C%AC%E7%9A%84%E4%BA%94%E5%A4%A7%E5%AE%9E%E7%94%A8%E6%96%B9%E6%B3%95\"><\/span>III. Five practical ways to reduce treatment costs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 id=\"h-3-1-\u9636\u68af\u5f0f\u6cbb\u7597\u7b56\u7565-\u4ece\u57fa\u7840\u5230\u5f3a\u5316\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"31_%E9%98%B6%E6%A2%AF%E5%BC%8F%E6%B2%BB%E7%96%97%E7%AD%96%E7%95%A5%EF%BC%9A%E4%BB%8E%E5%9F%BA%E7%A1%80%E5%88%B0%E5%BC%BA%E5%8C%96\"><\/span>3.1 Laddered treatment strategies: from basic to intensive<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Differentiated treatment plans for different stages of the disease can significantly optimize the cost structure:<\/p>\n<p><strong>Early intervention phase<\/strong>(Less severe symptoms):<\/p>\n<ul class=\"wp-block-list\">\n<li>option<strong>intravenous infusion<\/strong>Alternative to open heart surgery at a reduced cost 40%-50%<\/li>\n<li>adoption<strong>Outpatient day treatment<\/strong>Models to save hospitalization costs (e.g., Peking Union Medical College Hospital neural stem cell outpatient infusion service)<\/li>\n<\/ul>\n<p><strong>Intensive treatment in the middle and late stages<\/strong>(severe neurologic deficit):<\/p>\n<ul class=\"wp-block-list\">\n<li>acceptance<strong>Combined transplantation program<\/strong>: After initial surgical implantation, 1-2 additional subsequent IV infusions to maintain efficacy<\/li>\n<li>application (form etc)<strong>Hospital installments<\/strong>For example, Shanghai Huashan Hospital offers 12 interest-free installments, with a down payment of 30% to initiate treatment.<\/li>\n<\/ul>\n<h3 id=\"h-3-2-\u7cbe\u51c6\u5bf9\u63a5\u514d\u8d39\u533b\u7597\u8d44\u6e90\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"32_%E7%B2%BE%E5%87%86%E5%AF%B9%E6%8E%A5%E5%85%8D%E8%B4%B9%E5%8C%BB%E7%96%97%E8%B5%84%E6%BA%90\"><\/span>3.2 Accurate matching of free medical resources<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Official Clinical Research Platform<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>The China Clinical Trial Registry (ChiCTR) website searched for \"neural stem cells\" and found 17 open studies in the second quarter of 2025;<\/li>\n<li>Highlighted Recommended Projects:<strong>Research on \"iPSC-NSC transplantation for spinal cord injury\" at 301 Hospital<\/strong>(NCT2025-0412), which fully funds the cost of surgery and rehabilitation.<\/li>\n<\/ul>\n<p><strong>International multicenter trials<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>Participation in Phase III studies conducted by multinational pharmaceutical companies (e.g., Bayer's STAR-G trial) with subsidized international standard treatment and transportation<\/li>\n<li>Attention needs to be paid to the criteria for inclusion: the usual requirements<strong>No neurosurgery<\/strong>,<strong>Disease duration less than 5 years<\/strong>of patients 10<\/li>\n<\/ul>\n<h3 id=\"h-3-3-\u5584\u7528\u653f\u7b56\u5de5\u5177\u8de8\u7701\u62a5\u9500\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"33_%E5%96%84%E7%94%A8%E6%94%BF%E7%AD%96%E5%B7%A5%E5%85%B7%E8%B7%A8%E7%9C%81%E6%8A%A5%E9%94%80\"><\/span>3.3 Optimizing the use of policy tools for inter-provincial reimbursement<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Patients with off-site medical care can improve their reimbursement rates by standardizing the process:<\/p>\n<ol class=\"wp-block-list\" start=\"1\">\n<li><strong>Filing 30 days in advance<\/strong>: Submit a referral request and upload medical records through the National Health Insurance Service Platform (NHISP) APP;<\/li>\n<li><strong>Application for electronic vouchers<\/strong>: The health insurance bureau of the participating place issues the Inter-provincial Medical Care Voucher, which is synchronized to the hospital of consultation;<\/li>\n<li><strong>Direct settlement of claims<\/strong>: Swipe the card to settle the bill at designated hospitals (53 nationwide) that have opened direct compensation for different locations, and reimburse the 50%-70% basic medical expenses instantly.<\/li>\n<\/ol>\n<h2 id=\"h-\u56db-\u672a\u6765\u8d8b\u52bf\u4e0e\u60a3\u8005\u884c\u52a8\u6307\u5357\"><span class=\"ez-toc-section\" id=\"%E5%9B%9B%E3%80%81%E6%9C%AA%E6%9D%A5%E8%B6%8B%E5%8A%BF%E4%B8%8E%E6%82%A3%E8%80%85%E8%A1%8C%E5%8A%A8%E6%8C%87%E5%8D%97\"><\/span>IV. Future trends and guidelines for patient action<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 id=\"h-4-1-\u653f\u7b56\u4e0e\u6280\u672f\u9a71\u52a8\u7684\u964d\u4ef7\u8d8b\u52bf\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"41_%E6%94%BF%E7%AD%96%E4%B8%8E%E6%8A%80%E6%9C%AF%E9%A9%B1%E5%8A%A8%E7%9A%84%E9%99%8D%E4%BB%B7%E8%B6%8B%E5%8A%BF\"><\/span>4.1 Policy- and technology-driven price reduction trends<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The field of neural stem cell therapy is seeing two major drivers of change:<\/p>\n<p><strong>Direction of policy breakthroughs<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li>The State Drug Administration has placed the<strong>Neural stem cell preparations for spinal cord injury<\/strong>Included in priority review (batch 12 in 2024) and expected to be included in Medicare when approved for marketing in 2026<\/li>\n<li>Medicare Payment Reform: DRG Payment Pilot Includes Neurorestorative Treatments<strong>BJGD23 disease group<\/strong>The payment rate is about $400,000 per<\/li>\n<\/ul>\n<p><strong>Technology to reduce costs<\/strong>::<\/p>\n<ul class=\"wp-block-list\">\n<li><strong>3D bioreactor scale-up culture<\/strong>: Reduces cost of cell preparation by 30%-40% (Jiangsu Alp 2025 data)<\/li>\n<li><strong>Automated Cell Injection System<\/strong>: Reduced operating time by 60% and operating costs by 50% (Shanghai Ruijian Medical FibroTron System)<\/li>\n<\/ul>\n<h2 id=\"h-\u7ed3\u8bed-\u7406\u6027\u5e94\u5bf9\u8d39\u7528\u6311\u6218-\u628a\u63e1\u653f\u7b56\u8f6c\u578b\u673a\u9047\"><span class=\"ez-toc-section\" id=\"%E7%BB%93%E8%AF%AD%EF%BC%9A%E7%90%86%E6%80%A7%E5%BA%94%E5%AF%B9%E8%B4%B9%E7%94%A8%E6%8C%91%E6%88%98%EF%BC%8C%E6%8A%8A%E6%8F%A1%E6%94%BF%E7%AD%96%E8%BD%AC%E5%9E%8B%E6%9C%BA%E9%81%87\"><\/span>Conclusion: Rationalizing the Cost Challenge and Seizing the Opportunity for Policy Transformation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neural stem cell transplants, while costly, are made possible by the<strong>Step-by-step treatment strategy<\/strong>,<strong>Precise Policy Matching<\/strong>up to<strong>Innovative payment methods<\/strong>Patients are advised to pay close attention to the update of \"Clinical Guidelines for Cell Therapy Products\" issued by the Center for Drug Evaluation (CDE) of the State Administration of Pharmaceutical Affairs (SDPA), and at the same time to regularly check the \"National Health Insurance Service Platform\" APP for \"Stem Cell Therapy Pilot News\". Stem Cell Therapy Pilot Program\" in the app of \"National Health Insurance Service Platform\".<\/p>\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>important reminder<\/strong>Any service claiming to be \"stem cell cosmetic and anti-aging\" is illegal! Only 47 stem cell clinical studies have been approved by the State Food and Drug Administration (updated in 2025), which are mainly for<strong>neurological damage<\/strong>,<strong>disease of the blood<\/strong>and other serious diseases. Patients should choose medical institutions recorded by the National Health Commission (e.g. Beijing Tiantan Hospital, Shanghai Huashan Hospital, Neurosurgery Department of West China Hospital in Sichuan) to stay away from the cost traps of informal institutions.<\/p><\/blockquote>\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Disclaimer: This article is intended only to disseminate scientific knowledge and share industry perspectives, and does not constitute any clinical diagnostic advice! The information published by Hangi Stem Cells is not a substitute for the professional advice of a physician or pharmacist. If you have any questions about copyright or other issues, please feel free to contact me.<\/p><\/blockquote>","protected":false},"excerpt":{"rendered":"<p>\u622a\u81f32025\u5e746\u6708\uff0c\u795e\u7ecf\u5e72\u7ec6\u80de\u79fb\u690d\u7684\u5355\u6b21\u6cbb\u7597\u8d39\u7528\u57287\u4e07\u81f312\u4e07\u5143\u4eba\u6c11\u5e01\uff0c\u82e5\u9700\u957f\u671f\u591a\u6b21\u6cbb\u7597\uff08\u5982\u5e15\u91d1\u68ee\u75c5\u3001\u810a\u9ad3\u635f\u4f24\u7b49\uff09\uff0c\u603b\u8d39\u7528\u53ef\u80fd\u8fbe28\u4e07\u81f348\u4e07\u5143\u3002\u8d39\u7528\u4e3b\u8981\u6db5\u76d6\u7ec6\u80de\u5236\u5907\uff08\u536050%-60%\uff09\u3001\u624b\u672f\u690d\u5165\u3001\u672f\u540e\u76d1\u62a4\u53ca\u957f\u671f\u836f\u7269\u7ba1\u7406\u3002<\/p>","protected":false},"author":1,"featured_media":19267,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"gallery","meta":{"footnotes":""},"categories":[73],"tags":[164],"_links":{"self":[{"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/posts\/19268"}],"collection":[{"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/comments?post=19268"}],"version-history":[{"count":3,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/posts\/19268\/revisions"}],"predecessor-version":[{"id":19506,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/posts\/19268\/revisions\/19506"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/media\/19267"}],"wp:attachment":[{"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/media?parent=19268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/categories?post=19268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hjtdsm.cn\/en\/wp-json\/wp\/v2\/tags?post=19268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}